Catalyst Pharmaceuticals (CPRX) Short-term Investments (2011 - 2022)

Catalyst Pharmaceuticals (CPRX) has 12 years of Short-term Investments data on file, last reported at $9.9 million in Q2 2022.

• For the quarter ending Q2 2022, Short-term Investments fell 50.57% year-over-year to $9.9 million; the trailing twelve-month figure through Jun 2022 stood at $9.9 million (down 50.57% YoY), and the FY2021 full-year result was $19.8 million, up 97.4% from the prior year.
• Short-term Investments for Q2 2022 stood at $9.9 million, down from $19.4 million in the prior quarter.
• Across five years, Short-term Investments topped out at $58.5 million in Q2 2018 and bottomed at $5.0 million in Q4 2019.
• The 5-year median for Short-term Investments is $20.0 million (2021), against an average of $26.8 million.
• The widest annual swing landed in 2018, when Short-term Investments jumped 120.44%; it then sank 86.44% in 2019.
• A 5-year view of Short-term Investments shows it stood at $36.9 million in 2018, then tumbled by 86.44% to $5.0 million in 2019, then surged by 100.54% to $10.0 million in 2020, then soared by 97.4% to $19.8 million in 2021, then slumped by 50.17% to $9.9 million in 2022.
• The last three Short-term Investments figures came in at $9.9 million (Q2 2022), $19.4 million (Q1 2022), and $19.8 million (Q4 2021), per Business Quant data.

Peer Comparison